Personnel Moves Archives - Page 7 of 42

3M Health Care Group president is leaving ahead of spinoff

Departing 3M Health Care President Jeff Lavers. [Image from Jeff Lavers on LinkedIn]3M (NYSE: MMM) + announced today that Jeff Lavers, group president of its Health Care Business Group, intends to depart the company.

The departure of Lavers — which goes into effect on Dec. 1 — arrives in conjunction with the company’s planned Health Care spinoff. 3M said last month that it expects to complete that spinoff in early 2024.

The company said it plans for new Health Care CEO Bryan Hanson to continue leading the business as it works toward the spinoff. Hanson announced his departure from the corner office at Zimmer Biomet to take over the company in August. The company also landed former Insulet CFO Wayde McMillan as he takes over the same post.

3M Health Care is one of the largest medtech businesses in the world, with more than $8 billion in annual revenue.

The company also noted the departure of Ashish Khan…

Enable Injections adds finance veteran to its board

New Enable Injections board member Vickie Capps. [Image from NuVasive]Enable Injections announced today that it appointed Vickie Capps to its board of directors as the head of the audit committee.

Capps joins the wearable drug delivery system maker with plenty of experience in finance and executive leadership. She also brings extensive board experience, including currently serving on the board of orthopedic company NuVasive.

Other boards Capps serves on include Amedisys and Janux Therapeutics. She serves as a member of the senior advisory board at Consonance Capital Partners, a healthcare-focused private equity firm. Her record includes serving as CFO of DJO Global from 2002 to 2013 as well.

Capps joins the board of Enable Injections at a good time. The company just picked up FDA approval for its enFuse injector for the delivery of Empaveli.

Get the full story at our sister site, Drug Delivery Business News.

Cordis has a new CEO

Cordis CEO Scott Drake [Photo courtesy of Cordis]About two months after former Spectranetics CEO Scott Drake became executive board chair at Cordis, he’s moved into the corner office at the cardiology and endovascular devices company.

Drake replaces Shar Matin, who has stepped down as CEO, the company announced yesterday.

Hunter Philbrick, Hellman & Friedman partner and company board member, noted in a news release that Drake has been on the board since H&F acquired the company from Cardinal Health in 2021.

“He has a long history building world-class medical device organizations, bringing to market groundbreaking patient-saving innovations and driving commercial excellence — along with the reputation of attracting, retaining, and developing world-class talent. Scott believes in Cordis’ ability to transform the medical industry, and with him as CEO, Cordis will achieve its vision of pioneering breakthrough cardiovascular technologies.”

D…

Cordis has a new CEO

Cordis CEO Scott Drake [Photo courtesy of Cordis]About two months after former Spectranetics CEO Scott Drake became executive board chair at Cordis, he’s moved into the corner office at the cardiology and endovascular devices company.

Drake replaces Shar Matin, who has stepped down as CEO, the company announced yesterday.

Hunter Philbrick, Hellman & Friedman partner and company board member, noted in a news release that Drake has been on the board since H&F acquired the company from Cardinal Health in 2021.

“He has a long history building world-class medical device organizations, bringing to market groundbreaking patient-saving innovations and driving commercial excellence — along with the reputation of attracting, retaining, and developing world-class talent. Scott believes in Cordis’ ability to transform the medical industry, and with him as CEO, Cordis will achieve its vision of pioneering breakthrough cardiovascular technologies.”

D…

Silk Road Medical names a new CEO

Chas McKhann [Image from LinkedIn]Silk Road Medical (Nasdaq:SILK) announced today that it appointed Chas McKhann as its new CEO, effective immediately.

Located in Sunnyvale, California and Plymouth, Minnesota, Silk Road Medical is focused on reducing stroke risk through a carotid artery disease treatment called TransCarotid Artery Revascularization (TCAR). The company announced last month that CEO Erica Rogers intended to retire. She will continue serving as an advisor to the board.

The company’s plan included Rogers formally retiring once Silk Road completed the succession process. The company enlisted executive search firm Spencer Stuart to help find a replacement CEO. It now has a successor to the CEO who held the corner office for 11 years: Chas McKhann.

“Chas is a skilled and experienced leader with a track record of effectively building and scaling medical device businesses into underpenetrated markets. We are excited to welcome him to Silk Road…

The Mullings Group acquires M. J. Moore & Associates and names Michael Moore partner

NEWS RELEASE: The Mullings Group acquires M. J. Moore & Associates and names Michael Moore partner

Delray Beach, Florida (Nov. 1, 2023) – The Mullings Group, a leading talent acquisition firm headquartered in the U.S. specializing in medical & health technology, life sciences, and emerging high-tech industries, announces the acquisition of M. J. Moore & Associates. The founder of M. J. Moore & Associates, Michael Moore, will join the TMG team as a partner and continue building companies and careers within our industries.

TMG has over three decades of building companies and careers and is the industry’s largest and most successful search firm in the MedTech/HealthTech market, with offices in the U.S., Canada, the U.K., and APAC. The search firm is responsible for more than 8,000 successful searches with over 800+ clients ranging from multi-billion-dollar companies to emerging tech startups worldwide.

Mike has spent the past 25 years working…

Intuitive appoints Align Technology exec to its board

New Intuitive board member Sreelakshmi Kolli. [Image from Zimmer Biomet]Intuitive (Nasdaq: ISRG) + announced that it appointed Align Technology executive Sreelakshmi Kolli to its board of directors.

Kolli currently serves as EVP and chief digital officer at Align, the maker of Invisalign clear aligners and other dental tech. Her appointment to Intuitive’s board of directors went into effect on Oct. 27, 2023.

“Sree has deep expertise in applying technology to transform industries, enable business growth and drive strategy,” said Intuitive CEO Gary Guthart. “We look forward to her insights, particularly with respect to digital capabilities and meaningful customer experiences, as we continue to advance what’s possible in minimally invasive care.”

Kolli’s current role at Align holds responsibility for leading software, data, enterprise, cloud and infrastructure engineering. Her focus centers around the desi…

Cardio Flow announces first commercial FreedomFlow uses, appoints new COO

[Image courtesy of Cardio Flow]Cardio Flow today announced the successful completion of the first commercial cases for its FreedomFlow orbital atherectomy platform.

FreedomFlow, a device designed to treat peripheral artery disease (PAD), received FDA clearance earlier this month. Dr. Craig Walker, Dr. Pradeep Naier and Dr. McCall Walker performed the initial U.S. cases with the device. The procedures took place at the Cardiovascular Institute of the South (CIS) at the Terrebonne General Health System in Houma, Louisiana.

Cardio Flow designed FreedomFlow with a modern mechanism of action to clear plaque blockages in the arteries of the legs. The design uses the physics of angular momentum to create a spiral geometry. It puts five diamond-coated spheres in simultaneous contact with the vessel wall. The diamond-coated tip also helps ease the driveshaft through tight blockages.

The first patient treated at Terrebonne had complex arterial anatomy and multiple bl…

Neuromod tech developer Cognito Therapeutics has a new CCO

Christian Howell. [Image courtesy of Cognito Therapeutics]Cognito Therapeutics announced today that it named Christian Howell as its new chief commercial officer (CCO).

Cambridge, Massachusetts–based Cognito Therapeutics develops a non-invasive neuromodulation device that delivers proprietary gamma frequency light and sound stimulation. The company’s investigational device is intended to treat Alzheimer’s disease.

Howell joins the company with more than 20 years of medical device experience. His past includes responsibilities in business development, commercial leadership, product management, market development and strategy.

Before joining Cognito, Howell served as SVP and GM of Aetion’s medical device and diagnostic group. Prior to that, Howell had a nearly 15-year stint at Medtronic, leading its value-based healthcare partnerships organization. He also held P&L responsibility for Medtronic’s integrated health solutions program.

<…

Johnson & Johnson MedTech Chair Ashley McEvoy announces resignation

Former Johnson & Johnson MedTech Worldwide Chair Ashley McEvoy [Photo courtesy of Johnson & Johnson]Johnson & Johnson (NYSE: JNJ) + MedTech Worldwide Chair Ashley McEvoy plans to leave the world’s second-largest medical device manufacturer, she and J&J said today.

After 27 years with J&J — starting in consumer products and rising to the position of EVP and head of the company’s medical devices group — McEvoy gave her notice on Friday “to pursue new opportunities,” she said today.

McEvoy will stay on into the company’s first quarter, which starts in January 2024.

Medical Design & Outsourcing: Ashley McEvoy joins J&J’s top-paid executives

New Brunswick, New Jersey-based J&J has already appointed Tim Schmid, most recently J&J MedTech Asia Pacific (APAC) company group chair, as a J&J EVP and J&J MedTech’s new worldwide chair.

…

Ambu names new chief financial officer

Ambu today announced it appointed Henrik Skak Bender as chief financial officer, effective January 1, 2024.

Bender will replace Thomas Frederik Schmidt, who intends to step down on December 31. Under Schmidt’s leadership, the company said in a news release it returned to positive free cash flow and it has taken the first steps toward strong profitable growth. Ambu plans to focus on accelerating growth and improving profitability with Bender’s appointment.

“In the progression of Ambu’s Zoom In strategy, I have, together with the Board, decided to bring in a new leadership profile to execute on the next phase of Ambu’s transformation and growth journey. I am convinced that Henrik is the right profile for the CFO role at Ambu, as he brings strategic and operational experience from global companies, as well as the medical device industry. On behalf of myself and the Board, I want to thank Thomas for his contributions to Ambu, and I wish him the be…

Silk Road Medical CEO announces retirement

[Image courtesy of Silk Road Medical]Silk Road Medical (Nasdaq:SILK) today announced that CEO Erica Rogers plans to retire from the company.

Rogers will formally retire once the succession process is completed. The Sunnyvale, California-based company is working with executive search firm Spencer Stuart to find a replacement CEO.

“I’d like to thank Erica for her tremendous contributions to Silk Road over the last 11 years. Erica has been integral in leading and expanding the company’s strong operational infrastructure and commercial enterprise and driving a significant expansion of the use of Transcarotid Artery Revascularization (TCAR) and its impact on patients. She also has created an enduring, mission-focused culture at Silk Road, setting the Company apart,” Silk Road Chair Jack Lasersohn said in a news release. “The Silk Road Medical senior leadership team and Board of Directors are well-prepared for Erica’s transition. We plan to work closely together to ensu…